POLISCOPE
Topic4 documents tagged

Biosimilars

What This Page Covers

This page collects the 4 public records POLISCOPE has tagged with “Biosimilars”. Coverage spans bills - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Fda, and Drug Regulation.

Active Bills

Federal BillFEDERALJul 21, 2026Proposed Changes to Biosimilar Drug Review ProcessThis bill proposes changes to the Public Health Service Act to simplify and speed up the federal review process for biosimilar biological products. These are lower-cost versions of complex, high-cost

Recent Activity

No recent activity found for this topic in the available records yet.

Browse recent local activity →

Finance Signals

No finance signals found for this topic in the available records yet.

Trace money trail →

Open the Money page to search by entity, donor, or PAC.

Reported financial relationships and timing signals. This does not prove motive or influence.

Key Actors

  1. 01Committee on Health, Education, Labor, and Pensionsorganization1 mentions
  2. 02Bill Cassidyperson · R · Member of Congress1 mentions
  3. 03Food and Drug Administrationorganization1 mentions
  4. 04The Pew Charitable Trustsorganization1 mentions
  5. 05Michael C Burgessperson1 mentions
  6. 06U.S. Food and Drug Administrationorganization1 mentions
  7. 07Subcommittee on Primary Health and Retirement Securityorganization1 mentions
  8. 08Association for Accessible Medicinesorganization1 mentions
  9. 09Public Health Service Actconcept1 mentions

Connections Preview

Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.

  • Topic to billsProposed Changes to Biosimilar Drug Review Process
  • Topic to peopleBill Cassidy, Michael C Burgess
  • Topic to orgsCommittee on Health, Education, Labor, and Pensions, Food and Drug Administration, The Pew Charitable Trusts (+3 more)
Open the relationship graph →

Source Trail

Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.

  1. Jul 21, 2026Federal BillProposed Changes to Biosimilar Drug Review Process
  2. Jan 1, 2018hearing transcriptCongressional Hearing on FDA Drug Approval Fees
  3. Jan 1, 2017hearing transcriptSenate Hearing: FDA Progress on Biosimilar Drugs

Showing 3 of 4 source records.